The interesting thing now will be how long it might take for the burns phase 2 to wrap up and then what will the timeline be for completion of phase 3 and getting approval to market the product.
I am still hopefull that on completion of phase 2 burns if these results are reflected at the end then surely there would be a huge demand from hospitals for this product, and this might speed up the path to commercialisation. With the presentations recently to various groups monitoring AMR and following new anti biotics in the pipeline hopefully the demand will be immediate.
Maybe we will see what this fast track approval given by fda can do for us shortly?
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-65
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.8¢ |
Change
0.003(0.65%) |
Mkt cap ! $112.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.0¢ | 38.0¢ | $4.167K | 10.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24610 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 49817 | 1 |
View Market Depth
| Last trade - 15.44pm 31/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |